Form 483

GSK Vaccines S.r.l. Form 483, 2019-06-06

FDA issued a Form 483 to GSK Vaccines S.r.l. on 2019-06-06 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

GSK Vaccines S.r.l. · Siena, Italy · Issued June 6, 2019

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Jun 2019
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Omotunde O Osunsanmi, Darla J Christopher

6 Jun 2019
21 CFR 211.67(b)(2)

Cleaning SOPs/schedules

Cited by Omotunde O Osunsanmi, Darla J Christopher

6 Jun 2019
21 CFR 610.18(b)

Seed lots

Cited by Omotunde O Osunsanmi, Darla J Christopher

Inspected site

GVGSK Vaccines S.r.l.Siena, Italy

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 610.18(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere